IT Pharma presents Inbioamber, the new product of the Inbiotec line that combines hyaluronic acid with sodium succinate to achieve dermal rehabilitation and biostimulation to fight against inflammaging. This new synergy of assets constitutes the latest addition to the Inbiotec clinical cosmetics line, thus reaching 10 references. 5 in liquid format and 5 in lyophilized format.
Among the different theories of aging, there is one that relates inflammation and premature aging. This phenomenon is known as inflammaging. This concept describes the characteristic inflammatory state of aging associated with exposure to external agents such as UV radiation, pollution or stress, as well as a sedentary lifestyle, as well as internal effects related to metabolic and hormonal changes in the human body. Undoubtedly, exposure to this type of inflammatory factor becomes noticeable over the years and causes unwanted pigmentation of the skin, thinning of the epidermis, less firmness, and increased wrinkles. It is necessary to provide active antioxidants as well as substances that balance the inflammatory state of the body, reducing it to the maximum.
Thanks to its properties, Inbioamber manages to provide not only the immediate and deep hydration caused by hyaluronic acid, but also the reconstructive, regenerative and anti-inflammatory properties of sodium succinate, which is directly involved in the health and external appearance of skin tissue.
The biostimulation that we generate with Inbioamber occurs at the dermal level, stimulating cell oxygenation and microcirculation in such a way that we give the skin a rejuvenated and fresh appearance. Because chronic inflammation induces the aging of stem cells and inhibits their regenerative capacity, with Inbioamber we are able to reduce this aging process and slow down the biological clock.
The hyaluronic acid present in Inbioamber thickens the dermis and epidermis and generates a favorable ecosystem for the proliferation of fibroblasts that redensify the deeper layers of the skin, reducing the appearance of wrinkles and improving flaccidity.
Due to all these properties, this cosmetic product is focused on working through invasive therapies such as microneedling or less invasive therapies such as electroporation, not only in facial rejuvenation treatments but also, and most notably, in the treatment of acne in an inflammatory state. In addition, it serves as a complement to Inbioregen for the treatment of scars and stretch marks.
It is also an exceptional complement to carry out maintenance sessions with microneedling when a treatment with the IT Pharma injectable, Inbiotec Amber, has already been carried out, as well as to improve recovery times and reduce inflammatory processes after invasive treatments such as a laser or a peeling.
© 2020 ItPharma
